Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 173

1.

Healthcare provider compassion is associated with lower PTSD symptoms among patients with life-threatening medical emergencies: a prospective cohort study.

Moss J, Roberts MB, Shea L, Jones CW, Kilgannon H, Edmondson DE, Trzeciak S, Roberts BW.

Intensive Care Med. 2019 Jun;45(6):815-822. doi: 10.1007/s00134-019-05601-5. Epub 2019 Mar 25.

PMID:
30911803
2.

Identifying targets for cardiovascular medication adherence interventions through latent class analysis.

Cornelius T, Voils CI, Birk JL, Romero EK, Edmondson DE, Kronish IM.

Health Psychol. 2018 Nov;37(11):1006-1014. doi: 10.1037/hea0000661. Epub 2018 Sep 10.

PMID:
30198738
3.

Attention to threat in posttraumatic stress disorder as indexed by eye-tracking indices: a systematic review.

Lazarov A, Suarez-Jimenez B, Tamman A, Falzon L, Zhu X, Edmondson DE, Neria Y.

Psychol Med. 2019 Apr;49(5):705-726. doi: 10.1017/S0033291718002313. Epub 2018 Sep 4.

PMID:
30178728
4.

Monoamine Oxidases.

Edmondson DE, Binda C.

Subcell Biochem. 2018;87:117-139. doi: 10.1007/978-981-10-7757-9_5. Review.

PMID:
29464559
5.

Monoamine Oxidases, Oxidative Stress, and Altered Mitochondrial Dynamics in Cardiac Ageing.

Maggiorani D, Manzella N, Edmondson DE, Mattevi A, Parini A, Binda C, Mialet-Perez J.

Oxid Med Cell Longev. 2017;2017:3017947. doi: 10.1155/2017/3017947. Epub 2017 May 4. Review.

6.

Perceived Stress After Acute Myocardial Infarction: A Comparison Between Young and Middle-Aged Women Versus Men.

Xu X, Bao H, Strait KM, Edmondson DE, Davidson KW, Beltrame JF, Bueno H, Lin H, Dreyer RP, Brush JE, Spertus JA, Lichtman JH, DʼOnofrio G, Krumholz HM.

Psychosom Med. 2017 Jan;79(1):50-58. doi: 10.1097/PSY.0000000000000429.

7.

Risk for Incident Hypertension Associated With Posttraumatic Stress Disorder in Military Veterans and the Effect of Posttraumatic Stress Disorder Treatment.

Burg MM, Brandt C, Buta E, Schwartz J, Bathulapalli H, Dziura J, Edmondson DE, Haskell S.

Psychosom Med. 2017 Feb/Mar;79(2):181-188. doi: 10.1097/PSY.0000000000000376.

8.

Why p-OMe- and p-Cl-β-Methylphenethylamines Display Distinct Activities upon MAO-B Binding.

Fierro A, Edmondson DE, Celis-Barros C, Rebolledo-Fuentes M, Zapata-Torres G.

PLoS One. 2016 May 6;11(5):e0154989. doi: 10.1371/journal.pone.0154989. eCollection 2016.

9.

Design and synthesis of novel chalcones as potent selective monoamine oxidase-B inhibitors.

Hammuda A, Shalaby R, Rovida S, Edmondson DE, Binda C, Khalil A.

Eur J Med Chem. 2016 May 23;114:162-9. doi: 10.1016/j.ejmech.2016.02.038. Epub 2016 Feb 23.

PMID:
26974383
10.

Relations among depressive symptoms, electrocardiographic hypertrophy, and cardiac events in non-ST elevation acute coronary syndrome patients.

Whang W, Davidson KW, Palmeri NO, Bhatt AB, Peacock J, Chaplin WF, Shimbo D, Edmondson DE.

Eur Heart J Acute Cardiovasc Care. 2016 Sep;5(5):455-60. doi: 10.1177/2048872615610736. Epub 2015 Oct 8.

11.

Reversible and irreversible small molecule inhibitors of monoamine oxidase B (MAO-B) investigated by biophysical techniques.

Rojas RJ, Edmondson DE, Almos T, Scott R, Massari ME.

Bioorg Med Chem. 2015 Feb 15;23(4):770-8. doi: 10.1016/j.bmc.2014.12.063. Epub 2015 Jan 3.

12.

Beyond the Protein Matrix: Probing Cofactor Variants in a Baeyer-Villiger Oxygenation Reaction.

Martinoli C, Dudek HM, Orru R, Edmondson DE, Fraaije MW, Mattevi A.

ACS Catal. 2013;3(12):3058-3062.

13.

Truncated FAD synthetase for direct biocatalytic conversion of riboflavin and analogs to their corresponding flavin mononucleotides.

Iamurri SM, Daugherty AB, Edmondson DE, Lutz S.

Protein Eng Des Sel. 2013 Dec;26(12):791-5. doi: 10.1093/protein/gzt055. Epub 2013 Oct 29.

PMID:
24170887
14.
15.

Do MAO A and MAO B utilize the same mechanism for the C-H bond cleavage step in catalysis? Evidence suggesting differing mechanisms.

Orru R, Aldeco M, Edmondson DE.

J Neural Transm (Vienna). 2013 Jun;120(6):847-51. doi: 10.1007/s00702-013-0991-3. Epub 2013 Feb 16.

16.

Key barriers to medication adherence in survivors of strokes and transient ischemic attacks.

Kronish IM, Diefenbach MA, Edmondson DE, Phillips LA, Fei K, Horowitz CR.

J Gen Intern Med. 2013 May;28(5):675-82. doi: 10.1007/s11606-012-2308-x. Epub 2013 Jan 4.

17.

Precursor of ether phospholipids is synthesized by a flavoenzyme through covalent catalysis.

Nenci S, Piano V, Rosati S, Aliverti A, Pandini V, Fraaije MW, Heck AJ, Edmondson DE, Mattevi A.

Proc Natl Acad Sci U S A. 2012 Nov 13;109(46):18791-6. doi: 10.1073/pnas.1215128109. Epub 2012 Oct 29.

18.

Structural basis for benzothiazinone-mediated killing of Mycobacterium tuberculosis.

Neres J, Pojer F, Molteni E, Chiarelli LR, Dhar N, Boy-Röttger S, Buroni S, Fullam E, Degiacomi G, Lucarelli AP, Read RJ, Zanoni G, Edmondson DE, De Rossi E, Pasca MR, McKinney JD, Dyson PJ, Riccardi G, Mattevi A, Cole ST, Binda C.

Sci Transl Med. 2012 Sep 5;4(150):150ra121. doi: 10.1126/scitranslmed.3004395.

19.

Molecular Insights into Human Monoamine Oxidase B Inhibition by the Glitazone Anti-Diabetes Drugs.

Binda C, Aldeco M, Geldenhuys WJ, Tortorici M, Mattevi A, Edmondson DE.

ACS Med Chem Lett. 2011 Oct 15;3(1):39-42.

20.

Lights and shadows on monoamine oxidase inhibition in neuroprotective pharmacological therapies.

Binda C, Milczek EM, Bonivento D, Wang J, Mattevi A, Edmondson DE.

Curr Top Med Chem. 2011 Nov;11(22):2788-96. Review.

PMID:
22039878
21.

The 'gating' residues Ile199 and Tyr326 in human monoamine oxidase B function in substrate and inhibitor recognition.

Milczek EM, Binda C, Rovida S, Mattevi A, Edmondson DE.

FEBS J. 2011 Dec;278(24):4860-9. doi: 10.1111/j.1742-4658.2011.08386.x. Epub 2011 Nov 3.

22.

Structural properties of human monoamine oxidases A and B.

Binda C, Mattevi A, Edmondson DE.

Int Rev Neurobiol. 2011;100:1-11. doi: 10.1016/B978-0-12-386467-3.00001-7. Review.

PMID:
21971000
23.

²H kinetic isotope effects and pH dependence of catalysis as mechanistic probes of rat monoamine oxidase A: comparisons with the human enzyme.

Wang J, Edmondson DE.

Biochemistry. 2011 Sep 6;50(35):7710-7. doi: 10.1021/bi200951z. Epub 2011 Aug 16.

24.

Nitrogen kinetic isotope effects for the monoamine oxidase B-catalyzed oxidation of benzylamine and (1,1-(2)H2)benzylamine: nitrogen rehybridization and CH bond cleavage are not concerted.

MacMillar S, Edmondson DE, Matsson O.

J Am Chem Soc. 2011 Aug 17;133(32):12319-21. doi: 10.1021/ja205629b. Epub 2011 Jul 28.

PMID:
21786798
25.

Catalytic and inhibitor binding properties of zebrafish monoamine oxidase (zMAO): comparisons with human MAO A and MAO B.

Aldeco M, Arslan BK, Edmondson DE.

Comp Biochem Physiol B Biochem Mol Biol. 2011 Jun;159(2):78-83. doi: 10.1016/j.cbpb.2011.02.002. Epub 2011 Feb 23. Erratum in: Comp Biochem Physiol B Biochem Mol Biol. 2011 Oct;160(2-3):122.

26.
27.

Interactions of monoamine oxidases with the antiepileptic drug zonisamide: specificity of inhibition and structure of the human monoamine oxidase B complex.

Binda C, Aldeco M, Mattevi A, Edmondson DE.

J Med Chem. 2011 Feb 10;54(3):909-12. doi: 10.1021/jm101359c. Epub 2010 Dec 22.

28.

Potentiation of ligand binding through cooperative effects in monoamine oxidase B.

Bonivento D, Milczek EM, McDonald GR, Binda C, Holt A, Edmondson DE, Mattevi A.

J Biol Chem. 2010 Nov 19;285(47):36849-56. doi: 10.1074/jbc.M110.169482. Epub 2010 Sep 20.

29.

Biochemical, structural, and biological evaluation of tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and LSD2.

Binda C, Valente S, Romanenghi M, Pilotto S, Cirilli R, Karytinos A, Ciossani G, Botrugno OA, Forneris F, Tardugno M, Edmondson DE, Minucci S, Mattevi A, Mai A.

J Am Chem Soc. 2010 May 19;132(19):6827-33. doi: 10.1021/ja101557k.

PMID:
20415477
30.

2-Arylthiomorpholine derivatives as potent and selective monoamine oxidase B inhibitors.

Lühr S, Vilches-Herrera M, Fierro A, Ramsay RR, Edmondson DE, Reyes-Parada M, Cassels BK, Iturriaga-Vásquez P.

Bioorg Med Chem. 2010 Feb 15;18(4):1388-95. doi: 10.1016/j.bmc.2010.01.029. Epub 2010 Jan 15.

PMID:
20123154
31.

Expression of zebrafish (Danio rerio) monoamine oxidase (MAO) in Pichia pastoris: purification and comparison with human MAO A and MAO B.

Arslan BK, Edmondson DE.

Protein Expr Purif. 2010 Apr;70(2):290-7. doi: 10.1016/j.pep.2010.01.005. Epub 2010 Jan 14.

32.

Dual role of FMN in flavodoxin function: electron transfer cofactor and modulation of the protein-protein interaction surface.

Frago S, Lans I, Navarro JA, Hervás M, Edmondson DE, De la Rosa MA, Gómez-Moreno C, Mayhew SG, Medina M.

Biochim Biophys Acta. 2010 Feb;1797(2):262-71. doi: 10.1016/j.bbabio.2009.10.012. Epub 2009 Nov 10.

33.

High-level expression and purification of rat monoamine oxidase A (MAO A) in Pichia pastoris: comparison with human MAO A.

Wang J, Edmondson DE.

Protein Expr Purif. 2010 Apr;70(2):211-7. doi: 10.1016/j.pep.2009.10.013. Epub 2009 Oct 31.

34.

Serine 209 resides within a putative p38(MAPK) consensus motif and regulates monoamine oxidase-A activity.

Cao X, Rui L, Pennington PR, Chlan-Fourney J, Jiang Z, Wei Z, Li XM, Edmondson DE, Mousseau DD.

J Neurochem. 2009 Oct;111(1):101-10. doi: 10.1111/j.1471-4159.2009.06300.x. Epub 2009 Jul 23.

35.

Mutagenic probes of the role of Ser209 on the cavity shaping loop of human monoamine oxidase A.

Wang J, Harris J, Mousseau DD, Edmondson DE.

FEBS J. 2009 Aug;276(16):4569-81. doi: 10.1111/j.1742-4658.2009.07162.x. Epub 2009 Jul 23.

36.

Molecular and mechanistic properties of the membrane-bound mitochondrial monoamine oxidases.

Edmondson DE, Binda C, Wang J, Upadhyay AK, Mattevi A.

Biochemistry. 2009 May 26;48(20):4220-30. doi: 10.1021/bi900413g. Review.

37.

Inhibition of monoamine oxidase by (E)-styrylisatin analogues.

Van der Walt EM, Milczek EM, Malan SF, Edmondson DE, Castagnoli N Jr, Bergh JJ, Petzer JP.

Bioorg Med Chem Lett. 2009 May 1;19(9):2509-13. doi: 10.1016/j.bmcl.2009.03.030. Epub 2009 Mar 14.

38.

Development of spin-labeled pargyline analogues as specific inhibitors of human monoamine oxidases A and B.

Upadhyay AK, Edmondson DE.

Biochemistry. 2009 May 12;48(18):3928-35. doi: 10.1021/bi9002106.

39.

Structural and mechanistic studies of mofegiline inhibition of recombinant human monoamine oxidase B.

Milczek EM, Bonivento D, Binda C, Mattevi A, McDonald IA, Edmondson DE.

J Med Chem. 2008 Dec 25;51(24):8019-26. doi: 10.1021/jm8011867.

40.

Bioactive contaminants leach from disposable laboratory plasticware.

McDonald GR, Hudson AL, Dunn SM, You H, Baker GB, Whittal RM, Martin JW, Jha A, Edmondson DE, Holt A.

Science. 2008 Nov 7;322(5903):917. doi: 10.1126/science.1162395.

41.

Structural and mechanistic studies of arylalkylhydrazine inhibition of human monoamine oxidases A and B.

Binda C, Wang J, Li M, Hubalek F, Mattevi A, Edmondson DE.

Biochemistry. 2008 May 20;47(20):5616-25. doi: 10.1021/bi8002814. Epub 2008 Apr 22.

PMID:
18426226
42.

Characterization of detergent purified recombinant rat liver monoamine oxidase B expressed in Pichia pastoris.

Upadhyay AK, Edmondson DE.

Protein Expr Purif. 2008 Jun;59(2):349-56. doi: 10.1016/j.pep.2008.03.002. Epub 2008 Mar 10.

43.

Determination of the oligomeric states of human and rat monoamine oxidases in the outer mitochondrial membrane and octyl beta-D-glucopyranoside micelles using pulsed dipolar electron spin resonance spectroscopy.

Upadhyay AK, Borbat PP, Wang J, Freed JH, Edmondson DE.

Biochemistry. 2008 Feb 12;47(6):1554-66. doi: 10.1021/bi7021377. Epub 2008 Jan 17.

PMID:
18198902
44.
45.

Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs.

Binda C, Wang J, Pisani L, Caccia C, Carotti A, Salvati P, Edmondson DE, Mattevi A.

J Med Chem. 2007 Nov 15;50(23):5848-52. Epub 2007 Oct 4.

PMID:
17915852
46.

Structural insights into the mechanism of amine oxidation by monoamine oxidases A and B.

Edmondson DE, Binda C, Mattevi A.

Arch Biochem Biophys. 2007 Aug 15;464(2):269-76. Epub 2007 May 30. Review.

47.

Plasmalogen assembly: a key flavoenzyme.

Edmondson DE.

Structure. 2007 Jun;15(6):639-41.

48.

Human and rat monoamine oxidase-A are differentially inhibited by (S)-4-alkylthioamphetamine derivatives: insights from molecular modeling studies.

Fierro A, Osorio-Olivares M, Cassels BK, Edmondson DE, Sepúlveda-Boza S, Reyes-Parada M.

Bioorg Med Chem. 2007 Aug 1;15(15):5198-206. Epub 2007 May 22.

49.
50.

Do monomeric vs dimeric forms of MAO-A make a difference? A direct comparison of the catalytic properties of rat and human MAO-A's.

Wang J, Edmondson DE.

J Neural Transm (Vienna). 2007;114(6):721-4. Epub 2007 Mar 31.

PMID:
17401534

Supplemental Content

Loading ...
Support Center